Hester Biosciences shines on posting 30% sales growth in Q4

07 May 2019 Evaluate

Hester Biosciences is currently trading at Rs. 1525.00, up by 85.50 points or 5.94% from its previous closing of Rs. 1439.50 on the BSE.

The scrip opened at Rs. 1475.00 and has touched a high and low of Rs. 1556.45 and Rs. 1475.00 respectively. So far 840 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1672.20 on 14-May-2018 and a 52 week low of Rs. 1039.95 on 08-Oct-2018.

Last one week high and low of the scrip stood at Rs. 1499.00 and Rs. 1403.70 respectively. The current market cap of the company is Rs. 1310.06 crore.

The promoters holding in the company stood at 54.09%, while Institutions and Non-Institutions held 2.41% and 43.50% respectively.

Hester Biosciences has registered 30% sales growth at Rs 48.83 crore in Q4FY19 as against Rs 37.48 crore in the same period of the previous year. Sales for the FY19 also increased 27% at Rs 171.19 crore as compared to Rs 135.25 crore in FY18.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1670.30 15.15 (0.92%)
08-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6050.00
Cipla 1383.40
Zydus Lifesciences 1006.10
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.